At a glance
ClinicalIndex Comparison RecordN/ACompleted· 330 enrolled
Drug / intervention
Delefilcon A contact lenses (DAILIES TOTAL1®) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
In Brief
A clinical study evaluating Delefilcon A contact lenses (DAILIES TOTAL1®) and Narafilcon B contact lenses (1-DAY ACUVUE® TruEye®) for Myopia. Completed, enrolled 330 participants.
Detailed Summary
The purpose of this study was to compare the subjective performance of DAILIES TOTAL1® daily disposable contact lenses to that of 1-DAY ACUVUE® TruEye® daily disposable contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
First PostedJul 2012
Primary CompletionSep 2012
TodayJul 2026
First PostedJul 6, 2012
Enrollment StartJul 1, 2012
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.0 years ago
Interventions
Delefilcon A contact lenses (DAILIES TOTAL1®)device
Commercially marketed silicone hydrogel, single-vision contact lenses for daily wear, daily disposable use
Narafilcon B contact lenses (1-DAY ACUVUE® TruEye®)device
Commercially marketed, silicone hydrogel single-vision contact lenses for daily wear, daily disposable use